https://www.reedland.com/wp-content/uploads/2017/04/roche.jpg292560reedlandhttps://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.pngreedland2008-07-23 18:06:472017-04-25 18:09:39Roche Starts Acquisition Process of ARIUS to Gain Access to New Screening Platform for Antibody Therapeutics
https://www.reedland.com/wp-content/uploads/2017/04/Avanir-Pharma.jpg292560reedlandhttps://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.pngreedland2007-07-03 11:19:122017-04-26 11:27:41AVANIR Pharmaceuticals Announces Sale of FazaClo to Fund Continued Development of Zenvia
https://www.reedland.com/wp-content/uploads/2017/04/Depomed.jpg292560reedlandhttps://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.pngreedland2006-12-12 11:43:522017-04-26 11:48:19Depomed Announces Equity Financing Commitment of Up to $30 Million
